Literature DB >> 19947948

GIT1 is a novel MEK1-ERK1/2 scaffold that localizes to focal adhesions.

Ning Zhang1, Weihua Cai, Guoyong Yin, David J Nagel, Bradford C Berk.   

Abstract

Cell polarity is critical for cell migration and requires localized signal transduction in subcellular domains. Recent evidence demonstrates that activation of ERK1/2 (extracellular-signal-regulated kinase 1/2) in focal adhesions is essential for cell migration. GIT1 (G-protein-coupled receptor kinase-interacting protein 1) has been shown to bind paxillin and regulate focal-adhesion disassembly. We have previously reported that GIT1 binds to MEK1 [MAPK (mitogen-activated protein kinase)/ERK kinase 1] and acts as a scaffold to enhance ERK1/2 activation in response to EGF (epidermal growth factor). In the present study we show that GIT1 associates with ERK1/2 in focal adhesions and this association increases after EGF stimulation. The CC (coiled-coil) domain of ERK1/2 is required for association with GIT1, translocation to focal adhesions, and cell spreading and migration. Immunofluorescent staining showed that, after EGF stimulation, GIT1 co-localized with pERK1/2 (phosphorylated ERK1/2) in focal adhesions. The binding of GIT1 and ERK1/2 was functionally important, since transfecting an ERK2 mutant lacking the CC domain [ERK2(del CC)] significantly decreased pERK1/2 translocation to focal adhesions, cell spreading and migration induced by EGF. In summary, the CC domain of ERK1/2 is necessary for binding to GIT1, for ERK1/2 activation in focal adhesions, and for cell spreading and migration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19947948      PMCID: PMC3125965          DOI: 10.1042/CBI20090016

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  23 in total

1.  Biochemical and biological functions of the N-terminal, noncatalytic domain of extracellular signal-regulated kinase 2.

Authors:  S T Eblen; A D Catling; M C Assanah; M J Weber
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

2.  A conserved docking motif in MAP kinases common to substrates, activators and regulators.

Authors:  T Tanoue; M Adachi; T Moriguchi; E Nishida
Journal:  Nat Cell Biol       Date:  2000-02       Impact factor: 28.824

Review 3.  Integrin signaling in vascular biology.

Authors:  S J Shattil; M H Ginsberg
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

4.  Active ERK/MAP kinase is targeted to newly forming cell-matrix adhesions by integrin engagement and v-Src.

Authors:  V J Fincham; M James; M C Frame; S J Winder
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

5.  Membrane proximal ERK signaling is required for M-calpain activation downstream of epidermal growth factor receptor signaling.

Authors:  A Glading; F Uberall; S M Keyse; D A Lauffenburger; A Wells
Journal:  J Biol Chem       Date:  2001-04-23       Impact factor: 5.157

6.  GIT1 is a scaffold for ERK1/2 activation in focal adhesions.

Authors:  Guoyong Yin; Qinlei Zheng; Chen Yan; Bradford C Berk
Journal:  J Biol Chem       Date:  2005-05-27       Impact factor: 5.157

7.  MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade.

Authors:  H J Schaeffer; A D Catling; S T Eblen; L S Collier; A Krauss; M J Weber
Journal:  Science       Date:  1998-09-11       Impact factor: 47.728

8.  The protein kinase KSR interacts with 14-3-3 protein and Raf.

Authors:  H Xing; K Kornfeld; A J Muslin
Journal:  Curr Biol       Date:  1997-05-01       Impact factor: 10.834

9.  ADAM15 suppresses cell motility by driving integrin alpha5beta1 cell surface expression via Erk inactivation.

Authors:  Qin Chen; Ling-Hua Meng; Cai-Hua Zhu; Li-Ping Lin; He Lu; Jian Ding
Journal:  Int J Biochem Cell Biol       Date:  2008-02-26       Impact factor: 5.085

10.  ERK regulates Golgi and centrosome orientation towards the leading edge through GRASP65.

Authors:  Blaine Bisel; Yanzhuang Wang; Jen-Hsuan Wei; Yi Xiang; Danming Tang; Miguel Miron-Mendoza; Shin-ichiro Yoshimura; Nobuhiro Nakamura; Joachim Seemann
Journal:  J Cell Biol       Date:  2008-09-01       Impact factor: 10.539

View more
  13 in total

1.  MiR-491 attenuates cancer stem cells-like properties of hepatocellular carcinoma by inhibition of GIT-1/NF-κB-mediated EMT.

Authors:  Xiaojun Yang; Jing Ye; Han Yan; Zhaoyang Tang; Jian Shen; Jianping Zhang; Lihua Yang
Journal:  Tumour Biol       Date:  2015-07-19

2.  Brain-specific deletion of GIT1 impairs cognition and alters phosphorylation of synaptic protein networks implicated in schizophrenia susceptibility.

Authors:  Daniel M Fass; Michael C Lewis; Rushdy Ahmad; Matthew J Szucs; Qiangge Zhang; Morgan Fleishman; Dongqing Wang; Myung Jong Kim; Jonathan Biag; Steven A Carr; Edward M Scolnick; Richard T Premont; Stephen J Haggarty
Journal:  Mol Psychiatry       Date:  2022-05-03       Impact factor: 15.992

3.  G-protein-coupled receptor-2-interacting protein-1 is required for endothelial cell directional migration and tumor angiogenesis via cortactin-dependent lamellipodia formation.

Authors:  Syamantak Majumder; Mark P Sowden; Scott A Gerber; Tamlyn Thomas; Christine K Christie; Amy Mohan; Guoyong Yin; Edith M Lord; Bradford C Berk; Jinjiang Pang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-11-21       Impact factor: 8.311

Review 4.  The Arf-GAP and protein scaffold Cat1/Git1 as a multifaceted regulator of cancer progression.

Authors:  Sungsoo M Yoo; Richard A Cerione; Marc A Antonyak
Journal:  Small GTPases       Date:  2017-12-31

Review 5.  Accessory proteins of the RAS-MAPK pathway: moving from the side line to the front line.

Authors:  Silke Pudewell; Christoph Wittich; Neda S Kazemein Jasemi; Farhad Bazgir; Mohammad R Ahmadian
Journal:  Commun Biol       Date:  2021-06-08

6.  β-Arrestin2 is a critical component of the GPCR-eNOS signalosome.

Authors:  Songling Liu; Louis M Luttrell; Richard T Premont; Don C Rockey
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-13       Impact factor: 12.779

7.  GIT1 is a novel prognostic biomarker and facilitates tumor progression via activating ERK/MMP9 signaling in hepatocellular carcinoma.

Authors:  Junyi Chen; Pinghua Yang; Jue Yang; Zhijian Wen; Baohua Zhang; Xin Zheng
Journal:  Onco Targets Ther       Date:  2015-12-15       Impact factor: 4.147

8.  HER2/HER3 regulates lactate secretion and expression of lactate receptor mRNA through the MAP3K4 associated protein GIT1.

Authors:  Alejandro E Garcia-Flores; James J Sollome; Elangovan Thavathiru; Joseph L Bower; Richard R Vaillancourt
Journal:  Sci Rep       Date:  2019-07-25       Impact factor: 4.379

9.  MiR-138 inhibits cell proliferation and reverses epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting GIT1 and SEMA4C.

Authors:  Jiefang Li; Qinrong Wang; Ruiling Wen; Jieman Liang; Xiaoling Zhong; Wei Yang; Dongxiang Su; Jun Tang
Journal:  J Cell Mol Med       Date:  2015-08-18       Impact factor: 5.310

10.  Spatial intratumoural heterogeneity in the expression of GIT1 is associated with poor prognostic outcome in oestrogen receptor positive breast cancer patients with synchronous lymph node metastases.

Authors:  Ibai Goicoechea; Ricardo Rezola; María Arestin; María M Caffarel; Ana Rosa Cortazar; Lorea Manterola; Marta Fernandez-Mercado; María Armesto; Carla Sole; Erika Larrea; Angela M Araujo; Nerea Ancizar; Arrate Plazaola; Ander Urruticoechea; Arkaitz Carracedo; Irune Ruiz; Isabel Alvarez Lopez; Charles H Lawrie
Journal:  F1000Res       Date:  2017-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.